Literature DB >> 5360053

L-dopa and the negative symptoms of Parkinsonism.

H L Klawans, M Erlich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5360053      PMCID: PMC496559          DOI: 10.1136/jnnp.32.5.460

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  6 in total

1.  The pathogenesis of Parkinson's disease: a new hypothesis.

Authors:  A BARBEAU
Journal:  Can Med Assoc J       Date:  1962-10-13       Impact factor: 8.262

2.  Distribution of catechol compounds in human brain.

Authors:  I SANO; T GAMO; Y KAKIMOTO; K TANIGUCHI; M TAKESADA; K NISHINUMA
Journal:  Biochim Biophys Acta       Date:  1959-04

Review 3.  The pharmacology of parkinsonism (a review).

Authors:  H L Klawans
Journal:  Dis Nerv Syst       Date:  1968-12

4.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

Review 5.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

6.  The action of dopamine on neurones of the caudate nucleus.

Authors:  H McLennan; D H York
Journal:  J Physiol       Date:  1967-04       Impact factor: 5.182

  6 in total
  1 in total

1.  L-dopa in Parkinsonism associated with cerebellar dysfunction (probable olivopontocerebellar degeneration).

Authors:  H L Klawans; E Zeitlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-02       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.